SELENOP and hepatocellular carcinoma: Increased expression of LRP8, a low-density lipoprotein receptor that also functions as a receptor for selenoprotein P (SELENOP), was identified to promote ferroptosis resistance in breast cancer and hepatocellular carcinoma cell lines [10].